Cardiovascular Device Update articles from September 2005

Cardiovascular Device Update archives from September 2005

'Remarkable' effects on CVD from tight blood glucose control.
September 1, 2005... 'Remarkable' effects on CVD from tight blood glucose control By JIM STOMMEN CDU Executive Editor SAN DIEGO - Tight glucose control is widely known to lower cardiovascular disease (CVD) risk in Type 2 diabetics. Now, the same can...

Studies add to the ongoing debate over DES performance.
September 1, 2005... Studies add to the ongoing debate over DES performance By HOLLAND JOHNSON CDU Associate Managing Editor A host of studies unveiled this summer comparing the drug-eluting stents (DES) of Boston Scientific (Natick, Massachusetts) and...

International report.
September 1, 2005... International report Medtronic to launch DES in 40 countries A CDU Staff Report Medtronic (Minneapolis) reported early last month its receipt of the CE mark for its Endeavor Drug-Eluting Coronary Stent with Rapid Exchange Delivery...

Acquisitions.(Cardiac Science merger with Quinton Cardiology Systems)(Cyberquest acquires Vascular Relief Centers)(MicroMed Technology merges with Salmon Express subsidiary and will be named MicroMed Cardiovascular)
September 1, 2005... Acquisitions • Cardiac Science (Irvine, California), a manufacturer of public-access automated external defibrillators, reported that the Securities and Exchange Commission (SEC) has declared effective its statement related to its...

Business Developments.(St. Jude Medical enters stented tissue valve market)(departure of D. Keith Grossman of Thoratec)(Biophan Technologies expands product focus)
September 1, 2005... Business Developments First stented tissue valves for St. Jude St. Jude Medical (SJM; St. Paul, Minnesota), already a power in a variety of cardiovascular sectors, has entered the stented tissue valve market with the FDA approval last...

Agreements.
September 1, 2005... Agreements • Arrow International (Reading, Pennsylvania) reported entering into a three-year contract with Novation (Irving, Texas), the supply company of VHA and the University HealthSystem Consortium (UHC), for intra-aortic balloon...

Market Updates.
September 1, 2005... Market Updates Work on PediPump foresees pediatric use Ventricular assist devices (VADs) have revolutionized the treatment of cardiac disease in adults, improving survival for end-stage heart failure patients who would otherwise die...

Personnel File.
September 1, 2005... Personnel File • Thomas Trotter has been appointed CEO of AngioScore (Alameda, California), effective immediately. He succeeds Ephraim Heller, founder, chairman and CEO, who is retiring from the company. Trotter has more than 28...

Product Pipeline.
September 1, 2005... Product Pipeline CardioSight Service gets FDA approval Medtronic (Minneapolis) said last month that the FDA has approved its CardioSight Service, a service for cardiologists who are managing heart failure patients to monitor their...